SOURCE: MedEx Inc.

December 18, 2012 08:00 ET

Grass Roots Research and Distribution, Inc. Announces Investment Opinion on Medex, Inc. (MDXX)

SAN FRANCISCO, CA--(Marketwire - Dec 18, 2012) - Grass Roots Research and Distribution, Inc. (, the Investor Awareness Industry's Research Firm of Choice, announced today that it has initiated research coverage on Medex, Inc. (PINKSHEETS: MDXX) a medical support and services Company. The report was issued at a price of $0.10 with a target price of $0.53.

The Grass Roots report states that Medex, Inc. is focused on providing Medicare-accredited repair and rental services for wheelchairs and scooters. Medex plans to capitalize on the ageing U.S. population through development of "Repair Centers" and networking with medical equipment providers throughout the United States, especially the Major Metropolitan Statistical Areas which have a higher number of wheelchair users. With the growth in ageing population, the demand for patient mobility products has experienced a steep rise. As per the Medicare program, a power wheelchair cannot be replaced prior to 5 years from purchase but can be repaired as needed up to the original price of the chair. This offers the Company an opportunity to cash in on the billion dollar wheelchair and scooter industry. To sum it up, MDXX provides an enticing investment opportunity.

About Grass Roots Research and Distribution, Inc. (
The Grass Roots Research and Cohen Research brand names are the worldwide Gold Standard for micro cap/small cap research. Grass Roots have raised the art of fundamental securities research by forecasting the three statements and valuing all of its companies in three cases over a 5 year time period. Grass Roots distributes in-depth stock market research reports that highlight the company's market opportunity, technology, management, competition and other key differentiators that may affect their short and long term valuation.

About Medex, Inc.
MedEx, Inc. is a publicly traded, medical acquisition company focused on consolidating medical supply, medical technology and assisted living and care facility companies worldwide. Our goal is to be the best medical supply and Equipment Company providing products for people with disabilities, recovering from surgery, in rehabilitation facilities, nursing homes, assisted living centers and the elderly. MedEx is experiencing rapid growth through the acquisition of medical supply companies, medical technology companies, and assisted living and care facilities worldwide.

Cautionary Information Regarding Forward-Looking Statements:
Included in this news release and other information that the Company makes publicly available from time to time are forward-looking management comments and other statements that reflect management's current outlook for future periods. These statements include, among others, statements regarding the anticipated benefits from the development, production, or acquisition of new projects as well as anticipated revenue from other sources and which may be critical to the overall revenue and profits of the Company.

These statements and expectations are based on currently available competitive, financial and economic data along with the Company's operating plans, and are subject to future events and uncertainties that could cause anticipated events not to occur or actual results to differ materially from historical or anticipated results. Among the events or uncertainties which could adversely affect future periods are: changes in legal contingencies, the concentration of the Company's capital stock ownership etc. The forward-looking statements in this news release should be read in conjunction with the more detailed descriptions of the risk factors located in the Company's Registration Statement filed with the United States Securities and Exchange Commission. The Company undertakes no obligation to update or revise any forward-looking statements contained in this release as a result of new information or future events or developments.

This general purpose information, commercial advertisement, is not intended for investment advice. Do not base any investment decision on information herein. We do not endorse the truthfulness, completeness, accuracy or reliability of the information. This message and attachments are intended only for the use of the addressee. E-mails from this firm normally contain confidential and privileged material, and are for the sole use of the intended recipient. Use or distribution by an unintended recipient is prohibited, and may be a violation of law. If you believe that you received this e-mail in error, please do not read this e-mail or any attached items. Please delete the e-mail and all attachments, including any copies thereof, and inform the sender that you have deleted the e-mail, all attachments and any copies thereof. Thank you. This email is covered by the Electronic Communications Privacy Act, 18 U.S.C. 2510-2521 and is legally privileged. This communication may also contain material protected and governed by the Health insurance Portability and Accountability Act of 1996 (HIPAA). This e-mail is only for the personal and confidential use of the individuals to which it is addressed and contains confidential information. If you are not the intended recipient, you are notified that you have received this document in error, and that any reading, distributing, copying or disclosure is unauthorized. If you have received this communication in error, please notify the sender immediately by the telephone number above and destroy the message. Circular 230 Notice: Pursuant to recently-enacted U.S. Treasury Department regulations, we are now required to advise you that, unless otherwise expressly indicated, any federal tax advice contained in this communication, including attachments and enclosures, is not intended or written to be used, and may not be used, for the purpose of (i) avoiding tax-related penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any tax-related matters addressed herein. If you have received this message in error, notify the original sender or us by telephone or e-mail, and delete this message, along with any attachments.

Contact Information